Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-24 @ 2:22 PM
Ignite Modification Date:
2025-12-24 @ 2:22 PM
NCT ID:
NCT03657459
Eligibility Criteria:
Inclusion Criteria:
* Not referred for cardiac transplantation or ventricular assist device placement during the index hospitalization,
* Cognitively intact and able to view videos (adequate eyesight and hearing) with correction, if needed,
* Discharge to home, assisted living facility or to a family member's home and can control dietary sodium and fluids as needed,
* Willing to participate; which may require up to three (3) follow-up telephone calls post-discharge.
Exclusion Criteria:
* Chart documented psychiatric or cognitive conditions that limit ability to understand video content or adhere to self-care recommendations (Alzheimer's condition, dementia, schizophrenia, other neurological history that impairs memory or concentration),
* Plans to discharge to skilled nursing facility or hospice care,
* Receiving home hospice or palliative care; or has a medical condition reflecting less than 1 year of survival (cachexia, end stage liver disease or cancer or non-ambulatory New York Heart Association functional class IV HF),
* Hospitalized but at admission, in New York Heart Association functional class I or II HF
* Post-cardiac transplantation or ventricular assist device placement,
* Currently enrolled in another experimental HF research study,
* Chronic renal failure and receiving chronic hemodialysis therapy for an estimated glomerular filtration rate \< 15 mL/minute/1.73 m2,
* A non-traditional form of HF (hypertrophic or restrictive forms of cardiomyopathy, congenital heart disease or Takotsubo cardiomyopathy).
Healthy Volunteers:
False
Sex:
ALL
Minimum Age:
18 Years
Study:
NCT03657459
Study Brief:
Protocol Section:
NCT03657459